Fred E Cooperrider

Array ( [id] => 6805047 [patent_doc_number] => 20030232441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Antisense modulation of dual specific phosphatase 4 expression' [patent_app_type] => new [patent_app_number] => 10/174460 [patent_app_country] => US [patent_app_date] => 2002-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30402 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232441.pdf [firstpage_image] =>[orig_patent_app_number] => 10174460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805375 [patent_doc_number] => 20030232769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Antisense modulation of G protein-coupled receptor 39 expression' [patent_app_type] => new [patent_app_number] => 10/173902 [patent_app_country] => US [patent_app_date] => 2002-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31096 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232769.pdf [firstpage_image] =>[orig_patent_app_number] => 10173902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6805041 [patent_doc_number] => 20030232435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-18 [patent_title] => 'Antisense modulation of amyloid beta protein precursor expression' [patent_app_type] => new [patent_app_number] => 10/173208 [patent_app_country] => US [patent_app_date] => 2002-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30674 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20030232435.pdf [firstpage_image] =>[orig_patent_app_number] => 10173208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 694173 [patent_doc_number] => 07070931 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Cancer control' [patent_app_type] => utility [patent_app_number] => 10/167485 [patent_app_country] => US [patent_app_date] => 2002-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 10803 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/070/07070931.pdf [firstpage_image] =>[orig_patent_app_number] => 10167485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6874109 [patent_doc_number] => 20030194406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-16 [patent_title] => 'P-cadherin as a target for anti-cancer therapy' [patent_app_type] => new [patent_app_number] => 10/158123 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 34331 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20030194406.pdf [firstpage_image] =>[orig_patent_app_number] => 10158123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6678548 [patent_doc_number] => 20030228689 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Antisense modulation of G protein-coupled receptor kinase 6 expression' [patent_app_type] => new [patent_app_number] => 10/159856 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32019 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20030228689.pdf [firstpage_image] =>[orig_patent_app_number] => 10159856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 544674 [patent_doc_number] => 07163927 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-16 [patent_title] => 'Antisense modulation of kinesin-like 1 expression' [patent_app_type] => utility [patent_app_number] => 10/156603 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30507 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/163/07163927.pdf [firstpage_image] =>[orig_patent_app_number] => 10156603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688887 [patent_doc_number] => 20030032612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Oligonucleotides specific for the marORAB operon' [patent_app_type] => new [patent_app_number] => 10/153275 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9042 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032612.pdf [firstpage_image] =>[orig_patent_app_number] => 10153275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761879 [patent_doc_number] => 20030125241 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Therapeutic uses of LNA-modified oligonucleotides in infectious diseases' [patent_app_type] => new [patent_app_number] => 10/150779 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21508 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125241.pdf [firstpage_image] =>[orig_patent_app_number] => 10150779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 820610 [patent_doc_number] => 07407943 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-05 [patent_title] => 'Antisense modulation of apolipoprotein B expression' [patent_app_type] => utility [patent_app_number] => 10/147196 [patent_app_country] => US [patent_app_date] => 2002-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29617 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/407/07407943.pdf [firstpage_image] =>[orig_patent_app_number] => 10147196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6809026 [patent_doc_number] => 20030198965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-23 [patent_title] => 'Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression' [patent_app_type] => new [patent_app_number] => 10/126355 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30010 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20030198965.pdf [firstpage_image] =>[orig_patent_app_number] => 10126355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6378005 [patent_doc_number] => 20020119525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'TAB1 protein and DNA coding therefore' [patent_app_type] => new [patent_app_number] => 10/123427 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6327 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119525.pdf [firstpage_image] =>[orig_patent_app_number] => 10123427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6846854 [patent_doc_number] => 20030166021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Box-dependent Myc-interacting protein (BIN1) compositions and uses therefor' [patent_app_type] => new [patent_app_number] => 10/123807 [patent_app_country] => US [patent_app_date] => 2002-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26180 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166021.pdf [firstpage_image] =>[orig_patent_app_number] => 10123807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6326766 [patent_doc_number] => 20020197693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-26 [patent_title] => 'Novel molecules of the card-related protein family and uses thereof' [patent_app_type] => new [patent_app_number] => 10/118984 [patent_app_country] => US [patent_app_date] => 2002-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 41717 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20020197693.pdf [firstpage_image] =>[orig_patent_app_number] => 10118984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 397743 [patent_doc_number] => 07294712 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-13 [patent_title] => 'Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses' [patent_app_type] => utility [patent_app_number] => 10/095672 [patent_app_country] => US [patent_app_date] => 2002-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 10721 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/294/07294712.pdf [firstpage_image] =>[orig_patent_app_number] => 10095672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 742025 [patent_doc_number] => 07030236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Antisense oligonucleotides tarageting folate receptor alpha, and the use thereof' [patent_app_type] => utility [patent_app_number] => 10/093523 [patent_app_country] => US [patent_app_date] => 2002-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9438 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030236.pdf [firstpage_image] =>[orig_patent_app_number] => 10093523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6650546 [patent_doc_number] => 20030008306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Circular polynucleotide templates and methods for oligonucleotide synthesis' [patent_app_type] => new [patent_app_number] => 10/085395 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7086 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008306.pdf [firstpage_image] =>[orig_patent_app_number] => 10085395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750421 [patent_doc_number] => 20030044941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Human RNase III and compositions and uses thereof' [patent_app_type] => new [patent_app_number] => 10/079185 [patent_app_country] => US [patent_app_date] => 2002-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13063 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044941.pdf [firstpage_image] =>[orig_patent_app_number] => 10079185 [rel_patent_id] =>[rel_patent_doc_number] =>)